Breaking News Instant updates and real-time market news.

M

Macy's

$20.67

-2.36 (-10.25%)

, KSS

Kohl's

$39.50

-2.43 (-5.80%)

16:28
08/10/17
08/10
16:28
08/10/17
16:28

On The Fly: Top stock stories for Thursday

Stocks opened lower and remained in negative territory throughout the day as investors have increasingly moved to the sidelines over the last three days while the war of words between North Korea and the U.S. has escalated. The averages moved in a narrow range for most of the day, but the sellers pushed the market to its session lows in the late hours of trading as President Trump fired another salvo of strong admonition toward the communist nation. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 3,000 to 244,000 in the first week of August, reversing a 5,000 drop in the prior week to leave a fairly neutral start for the month. The Producer Price Index dipped 0.1% in July, missing expectations for a 0.1% increase, while the core PPI also slid 0.1%, versus expectations for a 0.2% increase. COMPANY NEWS: Shares of Macy's (M) dropped 10% after the department store operator announced better than expected top and bottom line results but reported another decline in comparable sales, marking the tenth straight quarter of decline for that closely watched measure. Macy's president and CEO Jeff Gennette said the second quarter results kept it on track to meet 2017 sales and earnings guidance, adding that the company expects the launch of its new loyalty program and marketing strategy to "further improve our sales trend in the back half of the year." Also lower was department store peer Kohl's (KSS), which fell nearly 6% despite reporting adjusted quarterly profits that beat expectations... 21st Century Fox (FOXA) shares were higher in early trading but finished flat after the broadcast and cable network operator reported earnings per share from continuing operations that beat estimates and revenue that fell slightly short of expectations. The media giant noted that it continued growing its cable channel and television businesses in the quarter through 8% growth in affiliate revenues and 5% advertising gains and added that investment in its video brands is "proving to be the right strategy"... Meanwhile, shares of Wells Fargo (WFC) slipped 1.5% amid broader weakness in the bank stocks as the Wall Street Journal reported that Stephen Sanger, nonexecutive chairman of the bank, could step down as part of a board shake-up. Board directors at the lender are looking to make final decisions of any changes by Labor Day, the Journal added. MAJOR MOVERS: Among the notable gainers was Perrigo (PRGO), which rallied 16% after its earnings and outlook beat expectations on the heels of several of the other companies in the generics space, headlined by Mylan (MYL) and Teva (TEVA), having recently lowered their own guidance. Also higher following its earnings report was Hudson Technologies (HDSN), which rose 16%. The company also announced a deal to buy Airgas-Refrigerants, a subsidiary of Airgas, which Craig-Hallum analyst Steven Dyer called a "transformative acquisition." Among the noteworthy losers was Blue Apron (APRN), which dropped 18% after the meal kit company reported its first quarterly results since its initial public offering. Also lower following their earnings reports were Chicago Bridge & Iron (CBI) and e.l.f. Beauty (ELF). INDEXES: The Dow fell 204.69, or 0.93%, to 21,844.01, the Nasdaq lost 135.46, or 2.13%, to 6,216.87, and the S&P 500 dropped 35.81, or 1.45%, to 2,438.21.

M

Macy's

$20.67

-2.36 (-10.25%)

KSS

Kohl's

$39.50

-2.43 (-5.80%)

FOX

21st Century Fox

$27.47

-0.04 (-0.15%)

APRN

Blue Apron

$5.14

-1.1 (-17.63%)

WFC

Wells Fargo

$51.95

-0.84 (-1.59%)

PRGO

Perrigo

$76.84

10.47 (15.78%)

HDSN

Hudson Technologies

$9.23

1.27 (15.95%)

CBI

CB&I

$11.97

-4.36 (-26.70%)

ELF

e.l.f. Beauty

$24.76

-0.41 (-1.63%)

FOXA

21st Century Fox

$27.88

-0.02 (-0.07%)

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 12

    Oct

  • 09

    Nov

  • 15

    Jan

M Macy's
$20.67

-2.36 (-10.25%)

06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
05/12/17
COWN
05/12/17
NO CHANGE
Target $29
COWN
Market Perform
Macy's financial modeling worrisome, says Cowen
Cowen analyst Oliver Chen said the rapid transformation of consumers' shopping preferences presents ongoing challenges to Macy's and other retailers. He said the company needs to reinvent promotional techniques that currently are yielding poor store traffic and higher markdowns. Chen said from a financial modeling perspective he is worried, leading him to maintain his Market Perform rating on Macy's shares and cut his price target to $29 from $44.
06/07/17
GSCO
06/07/17
NO CHANGE
Target $25
GSCO
Neutral
Macy's price target lowered to $25 from $28 at Goldman Sachs
Goldman analyst Lindsay Drucker Mann lowerd Macy's price target to $25 from $28 to reflect weaker margin trends and operating earnings following the company's Investor Day. The analyst is encouraged by the detail around strategic initiatives and has confidence in -3-4% FY17 comp guidance range. Shares are Neutral rated.
05/12/17
SBSH
05/12/17
NO CHANGE
Target $23
SBSH
Neutral
Macy's price target lowered to $23 from $30 at Citi
Citi analyst Paul Lejuez lowered his price target for Macy's to $23 saying the company's results yesterday "stood out as extremely weak" amid disappointing quarters across the sector. The analyst keeps a Neutral rating on the shares.
KSS Kohl's
$39.50

-2.43 (-5.80%)

08/08/17
OTRG
08/08/17
UPGRADE
OTRG
Mixed
Kohl's upgraded to Mixed from Negative at OTR Global
OTR Global raised its view on Kohl's to Mixed following checks that indicate Q2 sell-through at least met its plan with most vendors surveyed.
08/02/17
08/02/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wal-Mart (WMT) initiated with an Outperform at Oppenheimer. 2. Kohl's (KSS) assumed with a Buy at Jefferies. 3. Jabil Circuit (JBL) initiated with an Overweight at JPMorgan. 4. Bank of the Ozarks (OZRK) initiated with an Overweight at Morgan Stanley. 5. Sequans (SQNS) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
GDHS
08/10/17
UPGRADE
GDHS
Hold
Kohl's upgraded to Hold from Reduce at Gordon Haskett
Gordon Haskett upgraded Kohl's to Hold saying earnings downside looks limited post today's results. The firm raised its price target for the shares to $37 from $36.
08/10/17
JEFF
08/10/17
NO CHANGE
JEFF
Kohl's shares defended at Jefferies
FOX 21st Century Fox
$27.47

-0.04 (-0.15%)

08/08/17
BNCH
08/08/17
NO CHANGE
BNCH
Buy
Fox-ION 'rumors' most likely a negotiating tactic, says Benchmark
Benchmark analyst Daniel Kurnos highlighted a "slew" of "inconsistencies" that make him skeptical of last week's "unsubstantiated rumor published by Bloomberg" regarding Fox (FOXA) potentially forming a JV with ION and pulling all of its affiliate agreements from Sinclair (SBGI), concluding in a note to investors that this was "just another negotiating tactic by the network." Fox's "cozy" agreements with Tribune (TRCO) may get disrupted by Sinclair's acquisition, added Kurnos, who has a Buy rating on Sinclair shares.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $37
FBCO
Outperform
21st Century Fox, Sky deal to take longer to clear, says Credit Suisse
Credit Suisse analyst Omar Sheikh continues to believe the Sky (SKYAY) transaction will eventually receive full regulatory approval, but highlights there is an elevated risk to the deal if it is referred to the CMA, and at best an extended period before it gets cleared. Meanwhile, he believes the 2018 21st Century Fox (FOXA) organic equity story looks compelling, and reiterates an Outperform rating and $37 price target on the shares.
07/25/17
OTRG
07/25/17
DOWNGRADE
OTRG
Mixed
21st Century Fox downgraded to Mixed from Positive at OTR Global
OTR Global downgraded 21st Century Fox to Mixed from Positive
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
APRN Blue Apron
$5.14

-1.1 (-17.63%)

07/25/17
07/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Blue Apron (APRN) was initiated with a Buy at Citi and SunTrust. 2. Blue Buffalo Pet Products (BUFF) initiated with a Neutral at Baird 3. e.l.f. Beauty (ELF) initiated with a Buy at Citi. 4. Grainger (GWW) initiated with a Neutral at Northcoast. 5. Western Asset Mortgage (WMC) initiated with a Market Perform at JMP Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
STFL
08/04/17
NO CHANGE
STFL
Buy
Blue Apron not cutting staff levels, says Stifel
Stifel said Blue Apron is not cutting staff levels, but shifting its operations to the new Linden, NJ site later this year as part of a planned fulfillment-center migration process.
08/10/17
GSCO
08/10/17
DOWNGRADE
GSCO
Neutral
Blue Apron downgraded to Neutral from Buy at Goldman Sachs
08/10/17
GSCO
08/10/17
DOWNGRADE
Target $6
GSCO
Neutral
Goldman 'clearly wrong,' downgrades Blue Apron to Neutral
Goldman Sachs analyst Heath Terry downgraded Blue Apron to Neutral from Buy and cut his price target for the shares to $6 from $11 following the company's Q2 results. The shares in afternoon trading are down 19% to $5.05. Blue Apron management disclosed "significant operational issues" relating to its fulfillment center transition that will drive revenue dropping 20% in the second half of the year relative to the first half, Terry tells investors in a post-earnings research note. The company is also seeing higher churn and lower order rates due to higher error rates, the analyst adds. Terry admits to being "clearly wrong" on Blue Apron's logistical challenges and its ability to reaccelerate customer growth.
WFC Wells Fargo
$51.95

-0.84 (-1.59%)

07/31/17
BMOC
07/31/17
DOWNGRADE
BMOC
Market Perform
Citi downgraded on valuation, lack of catalysts at BMO Capital
As noted earlier, BMO Capital downgraded Citi (C) to Market Perform from Outperform. Analyst James Fotheringham downgraded the stock based on valuation and lack of catalysts. In conjunction with this note, he upgraded Wells Fargo (WFC) to Outperform from Market Perform and ended his pair trade call of going long Citi and short Wells Fargo. Target on Citi is $65.
07/31/17
BMOC
07/31/17
UPGRADE
BMOC
Market Perform
Wells Fargo upgraded to Market Perform from Underperform at BMO Capital
07/31/17
BMOC
07/31/17
UPGRADE
BMOC
Market Perform
Wells Fargo upgraded on valuation at BMO Capital
As noted earlier, BMO Capital upgraded Wells Fargo (WFC) to Market Perform from Underperform. Analyst JamesFotheringham upgraded the stock based on valuation. In conjunction with the note, the firm downgraded Citi (C) to Market Perform from Outperform, and ended its pair trade call of going long Citi and short Wells Fargo. Target on Wells Fargo is $49.
07/31/17
07/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Sector Perform from Underperform at RBC Capital with analyst Nik Modi saying he believes the FDA's tobacco announcement on Friday was "very much in line" with industry expectations despite the surprise to investors. 2. American Airlines (AAL) upgraded to Outperform from Market Perform at Cowen. 3. Baidu (BIDU) upgraded to Buy from Neutral at Nomura Instinet with analyst Jialong Shi-NIHK citing accelerating revenue momentum driven by news feed ads and an undervalued video business. 4. Wells Fargo (WFC) upgraded to Market Perform from Underperform at BMO Capital with analyst James Fotheringham citing valuation. The firm also ended its pair trade call of going long Citi (C) and short Wells Fargo. 5. GoPro (GPRO) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Yuuji Anderson saying valuation better reflects efforts to driver better product cycles through software improvements. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PRGO Perrigo
$76.84

10.47 (15.78%)

06/05/17
RBCM
06/05/17
DOWNGRADE
RBCM
Underperform
Perrigo downgraded on multiple headwinds at RBC Capital
As noted earlier, RBC Capital downgraded Perrigo to Underperform from Sector Perform. Analyst Randall Stanicky says that the growth rate of the company's U.S. consumer business "has structurally re-rated lower" amid pricing headwinds and share losses. He adds that the pressures facing the company's generic business will intensify, while its EBITDA growth will be "limited" and it will have difficulty meeting its lowered, 2%-4% revenue growth target. Price target to $60 from $66.
06/05/17
06/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Andy Hargreaves saying upside from the launch of iPhone 8 is already reflected in the shares. An "extremely strong iPhone 8 cycle" is being priced into the stock while little weight is being given to gross margins, supply issues, or the likelihood for declines beyond the iPhone 8, Hargreaves tells investors in a research note. 2. Perrigo (PRGO) downgraded to Underperform from Sector Perform at RBC Capital with analyst Randall Stanicky saying the growth rate of the company's U.S. consumer business "has structurally re-rated lower" amid pricing headwinds and share losses. 3. Endocyte (ECYT) downgraded to Neutral from Outperform at Wedbush and to Market Perform from Outperform at Cowen. 4. Affiliated Managers (AMG) was downgraded to Neutral from Buy at Citi while Federated Investors (FII) was downgraded to Sell from Neutral. 5. Veeva (VEEV) downgraded to Equal Weight from Overweight at Morgan Stanley with the firm's analyst saying the 60%+ move in shares year-to-date captures much of the near-term upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/16/17
CANT
06/16/17
INITIATION
Target $85
CANT
Overweight
Perrigo initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Louise Chen started Perrigo with an Overweight rating and $85 price target.
08/10/17
CANT
08/10/17
NO CHANGE
Target $93
CANT
Overweight
Perrigo price target raised to $93 from $85 at Cantor
Cantor analyst Louise Chen raised her price target on Perrigo to $93 from $85, citing higher expectations for its earnings and its multiple after the company's Q2 report and guidance increase. Chen, who thinks the company can grow on the top and bottom lines for every business segment in 2018, keeps an Overweight rating on Perrigo shares.
HDSN Hudson Technologies
$9.23

1.27 (15.95%)

08/10/17
CHLM
08/10/17
NO CHANGE
Target $10
CHLM
Buy
Hudson Tech acquisition of Airgas-Refrigerants a game changer, says Craig-Hallum
Craig-Hallum analyst Steven Dyer notes that Hudson Technologies (HDSN) delivered "solid" quarterly results and announced a transformative acquisition of Airgas-Refrigerants, a subsidiary of Airgas (ARG). The analyst believes the addition of Airgas will double Hudson Technologies' annual revenue and importantly adds scale, enhances the geographic footprint and customer base, and is expected to be "highly accretive" over time. Given its comparable size and myriad financial and competitive benefits, Dyer believes it could be "a game changer." He reiterates a Buy rating and $10 price target on Hudson Technologies' shares.
05/16/17
CHLM
05/16/17
NO CHANGE
Target $10
CHLM
Buy
Hudson Tech a likely beneficiary of refrigerant shortages, says Craig-Hallum
Craig-Hallum analyst Steven Dyer said his checks on certain HFC refrigerants indicate recent sharp price increases and his industry sources expect further hikes through the summer as supply shortages persist. Dyer, who sees the recent refrigerants price surge as likely to positively impact Hudson Technologies' revenue and margins, reiterates his Buy rating and $10 price target on the shares.
03/13/17
RILY
03/13/17
INITIATION
Target $9
RILY
Buy
Hudson Technologies resumed with a Buy at B. Riley
B. Riley analyst Ian Corydon resumed coverage of Hudson Technologies with a Buy rating and $9 price target.
CBI CB&I
$11.97

-4.36 (-26.70%)

08/10/17
DBAB
08/10/17
NO CHANGE
Target $21
DBAB
Buy
Deutsche Bank lays out path for CB&I shares getting back near $20
Deutsche Bank analyst Chad Dillard says that while CB&I's Q2 results "disappointed significantly," he sees a "clear path" to the shares trading towards the $20 range again should management execute and avoid further cos overruns. Selling the Technology business for 120% of the company's market value, deleveraging and reducing costs by $100M annually would unlock value, Dillard tells investors in a research note titled "2Q Results, A Tough (and Large) Pill to Swallow." The analyst lowered his price target for CB&I shares to $21 from $25 and maintains a Buy rating on the name. The stock in premarket trading is down 22%, or $3.58, to $12.75.
08/10/17
SBSH
08/10/17
NO CHANGE
Target $18
SBSH
Neutral
Citi cuts CB&I target, doesn't see 'big liquidity risk'
Citi analyst Andrew Kaplowitz says the seemingly forced sale of CB&I's Technology business is more concerning than he expected. Cost overruns on two gas plants and two U.S. Gulf coast LNG projects that resulted in $548M charges in the quarter seemed to force the company's hand, Kaplowitz tells investors in a research note. The good news, the analyst writes, it that he doesn't see "big liquidity risk" for CB&I because Technology is a "significantly valuable asset that should have lots of interested buyers." The analyst is concerned, however, that the charges in Q2 are "more the start and not the end" of CB&I's challenges. Kaplowitz lowered his price target for the shares to $18 from $20 and keeps a Neutral rating on the name.
08/10/17
DADA
08/10/17
NO CHANGE
DADA
CB&I reported 'dismal' Q2 results, but weakness overdone, says DA Davidson
DA Davidson analyst Brent Thielman says that CB&I reported "dismal" Q2 results, and the analyst slashed his price target on the shares to $25 from $40. However, he still believes that the company's EPS will rise to $4 "over time," and he believes that the weakness in the stock is overdone. Thielman keeps a Buy rating on the shares.
08/10/17
BARD
08/10/17
NO CHANGE
Target $10
BARD
Neutral
CB&I target cut to $10, cash burn puts balance sheet back in focus, says Baird
Baird analyst Andrew Wittmann said CB&I took significant project charges that, along with further cash burn, prompted immediate actions to avoid balance sheet pressure, which is now back in focus. He sees the cash burn likely continuing with ample risk stemming from further project degradation. Wittmann maintained his Neutral rating and lowered his price target to $10 from $24 on CB&I shares.
ELF e.l.f. Beauty
$24.76

-0.41 (-1.63%)

08/04/17
PIPR
08/04/17
NO CHANGE
Target $34
PIPR
Overweight
e.l.f. started rolling out in Ulta Beauty this week, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says her store checks indicate e.l.f. Beauty (ELF) started rolling out into 170-190 Ulta Beauty (ULTA) doors earlier this week. The analyst is "optimistic" that this in-store launch can be broader over time. Further, her channel checks in the U.K. indicate "broad strength" of sales at Superdrug. Checks suggest e.l.f.'s distribution growth initiatives remain on track and that it remains a share gainer, Murphy tells investors in a research note. She still sees the company as a potential takeout candidate "with time." The analyst has an Overweight rating on e.l.f. with a $34 price target.
08/10/17
PIPR
08/10/17
NO CHANGE
Target $32
PIPR
Overweight
e.l.f. Beauty gaining share amid industry deceleration, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says e.l.f. Beauty's sales in Q2 accelerated from Q1 despite ongoing industry deceleration in the category. She believes, however, that new money will wait to see further evidence of sales acceleration into the second half of 2017. The analyst lowered her price target for the shares to $32 from $34 and keeps an Overweight rating on e.l.f.
08/10/17
JEFF
08/10/17
NO CHANGE
Target $30
JEFF
Buy
e.l.f. Beauty results unlikely to reignite share momentum, says Jefferies
Jefferies analyst Stephanie Wissink says e.l.f. Beauty's Q2 report is likely enough to satisfy current shareholders and revive growth interest, but unlikely to "reignite momentum" in the shares. The analyst keeps a Buy rating on the shares with a $30 price target.
FOXA 21st Century Fox
$27.88

-0.02 (-0.07%)

07/14/17
WELS
07/14/17
NO CHANGE
WELS
Nexstar Fox deal positive, says Wells Fargo
Wells Fargo says the market is failing to fully appreciate Nexstar's (NXST) deal with 21st Century Fox (FOXA). The analyst says that the OTT master agreement within the deal was positive and removes an overhang on Nexstar. Wells says that the company's management "is doing everything right," and it recommends buying the stock now.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.